Reports
Global Non-Invasive Prenatal Testing (NIPT) Market Analysis: By Product and Service: Products, Services; By Method: Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA in Maternal Plasma Tests; By Application: Trisomy, Microdeletion Syndrome, Others; By End User; Regional Analysis; Competitive Landscape; 2024-2032
Global Non-Invasive Prenatal Testing (NIPT) Market Outlook
The global non-invasive prenatal testing (NIPT) market attained a value of about USD 1.74 billion in 2021. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 14.30% to reach nearly USD 3.88 billion by 2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America Represents a Considerable Share of the Market for Non-Invasive Prenatal Testing (NIPT)
North America holds a significant share of the non-invasive prenatal testing industry. This can be attributed to the high preterm birth rate, the robust healthcare infrastructure, and the rising maternal mortality rate. The increasing incidences of chromosomal abnormalities and the rising awareness regarding the benefits of non-invasive prenatal testing (NIPT) are propelling the growth of the market. With the rising focus of the leading companies on expanding their offerings of non-invasive prenatal testing (NIPT), their demand is witnessing robust growth and fuelling the market growth.
As major insurance companies are adding NIPT in coverage plans, their surging demand is anticipated to boost the market growth. Further, the introduction of new and technologically advanced tests is significantly contributing to the growth of the market in this region. Meanwhile, the Asia Pacific region is expected to grow significantly owing to the developing healthcare infrastructure in emerging countries such as China and India, among others. The increasing public healthcare expenditure and the rising awareness regarding non-invasive prenatal testing (NIPT) are anticipated to invigorate the market growth. Moreover, technological advancements and innovations in non-invasive prenatal testing (NIPT) are estimated to propel the market growth in the forecast period.
Non-invasive Prenatal Testing (NIPT): Market Segmentation
Non-invasive prenatal testing (NIPT), also known as non-invasive prenatal screening (NIPS), is a method of analysing the risk of genetic abnormalities in foetus. It is a safe and highly effective method of screening the conditions for Down syndrome, Edwards syndrome, Patau syndrome, and Turner syndrome, among others. This is generally done by analysing small fragments of DNA, circulating in pregnant women’s blood by 10 weeks of pregnancy.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on products and services, the market can be classified into:
- Products
- Services
The product segment is further bifurcated into consumables and instruments.
The major methods of non-invasive prenatal testing (NIPT) are:
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-Free DNA in Maternal Plasma Tests
The market can be broadly categorised on the basis of its applications into:
- Trisomy
- Microdeletion Syndrome
- Others
On the basis of end user, the market can be segmented into:
- Diagnostic Laboratories
- Hospitals
The EMR report looks into the regional markets of non-invasive prenatal testing (NIPT) like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
High risk of Chromosomal Abnormalities Driving the Market Growth of Non-Invasive Prenatal Testing (NIPT)
The high risk of chromosomal abnormalities and the increasing maternal age are propelling the growth of non-invasive prenatal testing industry. As pregnancy above 35 years has a higher risk of genetic abnormalities, the demand for non-invasive prenatal testing (NIPT) is increasing. Obstetricians are increasingly recommending patients to undergo non-invasive tests to ensure healthy delivery of babies, hence fuelling the industry growth. Furthermore, the increasing research activities for the development of advanced technologies for NIPT are projected to propel the market growth. With technological advancements, the cost-effectiveness of non-invasive prenatal testing (NIPT) is increasing, which is estimated to bolster the market growth in upcoming years.
The increasing government spending on research and development (R&D) activities on non-invasive prenatal testing (NIPT) is expected to drive the market growth. Various laboratories and companies are providing advanced non-invasive prenatal testing (NIFT) to patients, which is propelling the growth of non-invasive prenatal testing industry. Moreover, the growing incidences of genetic disorders and the increasing public healthcare expenditure and growing awareness are estimated to propel the market growth in the forecast period.
Key Industry Players in the Global Non-Invasive Prenatal Testing (NIPT) Market
The report presents a detailed analysis of the following key players in the global non-invasive prenatal testing (NIPT) market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Illumina, Inc.
- Thermo Fisher Scientific Corporation
- PerkinElmer, Inc.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche AG
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product and Service, Method, Application, End User, Region |
| Breakup by Product and Service | Products, Services |
| Breakup by Method | Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA in Maternal Plasma Tests |
| Breakup by Application | Trisomy, Microdeletion Syndrome, Others |
| Breakup by End User | Diagnostic Laboratories, Hospitals |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Illumina, Inc., Thermo Fisher Scientific Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Non-Invasive Prenatal Testing (NIPT) Market Analysis
8.1 Key Industry Highlights
8.2 Global Non-Invasive Prenatal Testing (NIPT) Historical Market (2018-2023)
8.3 Global Non-Invasive Prenatal Testing (NIPT) Market Forecast (2024-2032)
8.4 Global Non-Invasive Prenatal Testing (NIPT) Market by Product and Service
8.4.1 Products
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.3 Breakup by Type
8.4.1.3.1 Consumables
8.4.1.3.2 Instruments
8.4.2 Services
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.5 Global Non-Invasive Prenatal Testing (NIPT) Market by Method
8.5.1 Ultrasound Detection
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Biochemical Screening Tests
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Cell-Free DNA in Maternal Plasma Tests
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.6 Global Non-Invasive Prenatal Testing (NIPT) Market by Application
8.6.1 Trisomy
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Microdeletion Syndrome
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Others
8.7 Global Non-Invasive Prenatal Testing (NIPT) Market by End User
8.7.1 Diagnostic Laboratories
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Hospitals
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.8 Global Non-Invasive Prenatal Testing (NIPT) Market by Region
8.8.1 North America
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 Europe
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.8.3 Asia Pacific
8.8.3.1 Historical Trend (2018-2023)
8.8.3.2 Forecast Trend (2024-2032)
8.8.4 Latin America
8.8.4.1 Historical Trend (2018-2023)
8.8.4.2 Forecast Trend (2024-2032)
8.8.5 Middle East and Africa
8.8.5.1 Historical Trend (2018-2023)
8.8.5.2 Forecast Trend (2024-2032)
9 North America Non-Invasive Prenatal Testing (NIPT) Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Non-Invasive Prenatal Testing (NIPT) Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Non-Invasive Prenatal Testing (NIPT) Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Illumina, Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Thermo Fisher Scientific Corporation
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 PerkinElmer, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Agilent Technologies, Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 F. Hoffmann-La Roche AG
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Non-Invasive Prenatal Testing (NIPT) Market: Key Industry Highlights, 2018 and 2032
2. Global Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Product and Service (USD Billion), 2018-2023
3. Global Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Product and Service (USD Billion), 2024-2032
4. Global Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Method (USD Billion), 2018-2023
5. Global Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Method (USD Billion), 2024-2032
6. Global Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Application (USD Billion), 2018-2023
7. Global Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Application (USD Billion), 2024-2032
8. Global Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by End User (USD Billion), 2018-2023
9. Global Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by End User (USD Billion), 2024-2032
10. Global Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Region (USD Billion), 2018-2023
11. Global Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Region (USD Billion), 2024-2032
12. North America Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Country (USD Billion), 2018-2023
13. North America Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Europe Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Europe Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Asia Pacific Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Latin America Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Latin America Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Global Non-Invasive Prenatal Testing (NIPT) Market Structure
Key Questions Answered in the Report
In 2021, the global non-invasive prenatal testing (NIPT) market attained a value of nearly USD 1.74 billion.
The market is projected to grow at a CAGR of 14.30% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 3.88 billion by 2027.
The increasing incidence of chromosomal abnormalities and the increasing maternal age are driving the growth of non-invasive prenatal testing industry.
The industry is expected to be propelled by the rising incidences of genetic disorders, the increasing government spendings on research and development (R&D) activities, and technological advancements.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant products and services of non-invasive prenatal testing (NIPT) are products and services.
Ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests are the major methods of non-invasive prenatal testing (NIPT) in the industry.
The various applications of non-invasive prenatal testing (NIPT) are trisomy and microdeletion syndrome, among others.
Diagnostic laboratories and hospitals are different end users of non-invasive prenatal testing (NIPT).
The major players in the industry are Illumina, Inc., Thermo Fisher Scientific Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., and F. Hoffmann-La Roche AG, among others.
Analyst Review
The global non-invasive prenatal testing (NIPT) market attained a value of about USD 1.74 billion in 2021, driven by the rising incidence of chromosomal abnormalities. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 14.30%. The market is projected to reach nearly USD 3.88 billion by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By product and service, the non-invasive prenatal testing (NIPT) industry can be bifurcated into products and services. On the basis of method, the market is classified into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests. Based on its application, the market can be segmented into trisomy and microdeletion syndrome, among others. On the basis of end users, the market is divided into diagnostic laboratories and hospitals. The major regional markets for non-invasive prenatal testing (NIPT) are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Illumina, Inc., Thermo Fisher Scientific Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., and F. Hoffmann-La Roche AG, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER